BioCatalyst

PHAT — Phathom Pharmaceuticals, Inc. catalysts

1 verified catalyst event(s) for Phathom Pharmaceuticals, Inc. (ticker PHAT). Each is linked to its official source. Verified as of 2026-09-20.

Next verified catalyst

2026-10-01 — A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo Af · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10 (month)
in 11d
ESTIMATED
 READOUT
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to
Phase 2 · Eosinophilic Esophagitis
 PHAT Phathom Pharmaceuticals, Inc Vonoprazan ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.